Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors - Wikidata - wikimedia - TriplyDB

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

http://www.wikidata.org/entity/Q33416674

about

Biosafe nanoscale pharmaceutical adjuvant materials Rational approaches to improving selectivity in drug design Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density Targeted drug delivery systems mediated by a novel Peptide in breast cancer therapy and imaging Peptide-mediated liposomal Doxorubicin enhances drug delivery efficiency and therapeutic efficacy in animal models NGR-peptide-drug conjugates with dual targeting properties.Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting Combinatorial peptide libraries: mining for cell-binding peptides.Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications.Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer Targeting of drugs and nanoparticles to tumors.Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis.Antibody phage display libraries: contributions to oncology.Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery Advancement and applications of peptide phage display technology in biomedical science Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.Peptide targeted lipid nanoparticles for anticancer drug delivery.Systematic review: the applications of nanotechnology in gastroenterology.Nanotechnological strategies for therapeutic targeting of tumor vasculature.Current trends in the use of liposomes for tumor targeting Nanopreparations to overcome multidrug resistance in cancer.The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy.Increasing the antitumor efficacy of doxorubicin-loaded liposomes with peptides anchored via a chelator lipid.1H NMR detection of mobile lipids as a marker for apoptosis: the case of anticancer drug-loaded liposomes and polymeric micelles.Delivery of negatively charged liposomes into the atherosclerotic plaque of apolipoprotein E-deficient mouse aortic tissue.Application of Light Scattering Techniques to Nanoparticle Characterization and Development.

P2860

Q26829798-74E95A26-987C-4092-B9C2-402A0D9DE595 Q26865357-B6360481-8EA4-47F0-B739-C6401D38932D Q27024850-29B0CA8C-7FCC-45FB-BF06-80F5116DC4DD Q27308658-1462850D-2C29-4587-A01A-059DC8DEE84E Q28533782-E293D9B6-2C9C-4348-A440-59F58CC8D5C5 Q28538039-2A6EC31A-7D86-44A6-B2B3-EA778784AD71 Q30354486-A92DB59E-95AE-4DFE-8886-933CFF735EF3 Q30456053-AC90B06C-9940-4AE9-A111-D323059140D3 Q31144876-1A6E2690-97EE-4D19-A762-7A01E834D152 Q33520512-93B58C45-0A8A-4546-8B63-C9F262566568 Q33584756-DD3CF4F3-1ED1-4736-8F1E-3B084C5E9122 Q33751710-40FDDA55-339F-40FC-BB5B-D50103981A90 Q33829569-3B1A575A-D276-40F7-B922-5F4F6C27B288 Q33964836-C6071359-8F7E-447A-BBEF-D702D1A9E5DF Q34323991-A7010C46-2509-4512-BBAB-CBB33200B832 Q35783096-6F10E82A-D486-480C-AC52-EBE838C87250 Q35809872-9A9A2291-E734-419F-BC75-B948F4F79D53 Q35898339-4F5E089A-3DE1-421F-9D3F-795F8EC6B21E Q36425431-CBEE7BDA-606B-4AD8-843C-F5AECBF68784 Q37638947-B0912843-0358-404F-920B-56C030EE2343 Q37999793-9AB866D0-B032-40C0-A3ED-0673BC26B445 Q38016810-430B7363-6A44-45F1-A0B1-F58450225D6C Q38017701-38E412CE-D1F6-4677-8956-C6E203974E26 Q38120320-1B372E97-0B9B-4D83-BDD7-DFD725F56AA9 Q38126543-C6AEFDCC-C720-4F99-867A-BD40BE4D5976 Q38131264-2EEF02E8-E0A0-4120-892F-9688B9781C49 Q38941448-0D6996AF-351E-446B-8FEE-2F542F789262 Q39622438-888F4BC6-C0D1-4AB9-B1E2-05A8547B07AD Q39802375-BDB279E7-52BD-4191-9FD5-3AD771A589D0 Q40659715-192BB044-63F9-456A-BB77-756B745CC28D Q55516366-9BF631A5-5727-4CF8-80CE-349EC6FB8DEE

P2860

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

http://www.wikidata.org/entity/Q33416674

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

@ast

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

@en

type

label

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

@ast

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

@en

prefLabel

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

@ast

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

@en

P1433

Q33416674-4814C457-B962-4D90-9E65-BBA9F6AEFABF

P1476

Q33416674-F25086C1-591C-4B89-88F8-C2D043285DF7

P2093

Q33416674-046379C7-8BB8-404B-A91D-0DD53928E181

Q33416674-0A40FA60-9658-48B0-8F3A-F8E7C8953B5B

Q33416674-24411A88-CBF7-4501-AA98-06C8DED7F581

Q33416674-578C8467-CFDC-44B5-B274-E0941C9FA97C

Q33416674-83EF2815-1190-49CD-B258-24365EC0EFBE

Q33416674-8B2618F7-CF80-4D55-881F-E5B904FB9C19

Q33416674-CD1C21D3-91D8-4B03-BD35-47E3BD74F0E7

P2860

Q33416674-06D915D8-5339-4E70-B483-8D59CDCDAD1B

Q33416674-06D9D88B-255C-4A4B-83FB-864F25453DD5

Q33416674-08209C1B-3BC7-4E62-8BCC-E1D4C1B37C17

Q33416674-0F647F15-E7B9-49FF-86C0-473CC8E0D17B

Q33416674-193935DA-6D09-48D7-8581-811738B2780A

Q33416674-1C262B2D-4C39-4468-8485-3F4C8C38A886

Q33416674-1D8CC961-5C2F-4596-8DF2-9B1996ADDA89

Q33416674-213FE486-6F99-4DB3-A3AD-8662D908F6EA

Q33416674-2B76FC3A-EF8B-442F-9D30-31A2516D818A

Q33416674-34C59D9B-0746-4486-B26D-11628410D68E

P304

Q33416674-6B8875BA-01F0-4FF2-9603-5F60519103C1

P31

Q33416674-2ECDE0B9-C719-496B-B263-D41563A9DCCA

P356

Q33416674-029B6BED-E3CE-4619-982B-002F374738E5

P407

Q33416674-AA2BE2CF-C4ED-4847-A33C-78CC9242FCC7

P433

Q33416674-D8A0AE87-C1BF-4D0D-8162-27816DC12B60

P478

Q33416674-4A0D1D9E-9254-4406-B6CF-30C57E964ECC

P50

Q33416674-462423CF-051D-4E48-B29D-17FCC0F94ACB

P577

Q33416674-94E4D2A6-F02F-4B89-9A16-856723B5AA41

P5875

Q33416674-5B175645-D85D-4BAB-ACAC-446CAA83C420

P698

Q33416674-F6AC583E-2C2C-46DE-B3AD-03E613FDF20D

P932

Q33416674-A5296C29-D96A-40FD-93CF-883940B17625

P356

P1433

Journal of Biological Chemistry

P1476

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

@en

P2093

Albert Lo

http://www.w3.org/2001/XMLSchema#string

Chien-Yu Chiu

http://www.w3.org/2001/XMLSchema#string

De-Kuan Chang

http://www.w3.org/2001/XMLSchema#string

Han-Chung Wu

http://www.w3.org/2001/XMLSchema#string

Pi-Chun Li

http://www.w3.org/2001/XMLSchema#string

Szu-Yao Kuo

http://www.w3.org/2001/XMLSchema#string

Wei-Chuan Lin

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF inhibition and renal thrombotic microangiopathy

Openings between defective endothelial cells explain tumor vessel leakiness

Generation and Characterization of Monoclonal Antibodies against Dengue Virus Type 1 for Epitope Mapping and Serological Detection by Epitope-Based Peptide Antigens

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee

A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Drug delivery systems: entering the mainstream

High interstitial fluid pressure - an obstacle in cancer therapy

P304

12905-12916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M900280200

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24191250

http://www.w3.org/2001/XMLSchema#string

P698

19276080

http://www.w3.org/2001/XMLSchema#string

P932

2676021

http://www.w3.org/2001/XMLSchema#string